Singapore markets closed
Straits Times Index
3,307.90 -6.15 (-0.19%) Nikkei
38,946.93 -122.75 (-0.31%) Hang Seng
19,220.62 -415.60 (-2.12%) FTSE 100
8,416.45 -7.75 (-0.09%) Bitcoin USD
70,185.55 -1,070.88 (-1.50%) CMC Crypto 200
1,526.32 +37.78 (+2.54%)
BCRX Sep 2024 7.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:13AM EDT. Market open.
| Previous close | 2.7500 |
| Open | 2.7500 |
| Bid | 1.1500 |
| Ask | 1.3000 |
| Strike | 7.00 |
| Expiry date | 2024-09-20 |
| Day's range | 2.7500 - 2.7500 |
| Contract range | N/A |
| Volume | |
| Open interest | 40 |
GuruFocus.comInsider Buying: Chief R&D Officer Helen Thackray Acquires 30,000 Shares of BioCryst ...
Helen Thackray, Chief Research & Development Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30,000 shares of the company on May 14, 2024.
GuruFocus.comDirector Steven Galson Acquires 21,940 Shares of BioCryst Pharmaceuticals Inc (BCRX)
On May 13, 2024, Steven Galson, a Director at BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 21,940 shares of the company, as reported in a recent SEC Filing.
GuruFocus.comInsider Buying: Charles Gayer Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX)
Charles Gayer, Chief Commercial Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30,000 shares of the company on May 13, 2024.
© 2024 Yahoo. All rights reserved.